Drouin Annick, Thorin Eric
Institut de Cardiologie de Montréal, Centre de Recherche, Montréal, Québec, Canada.
Stroke. 2009 May;40(5):1827-33. doi: 10.1161/STROKEAHA.108.536805. Epub 2009 Mar 12.
Endothelial nitric oxide synthase produces superoxide under physiological conditions leading to hydrogen peroxide (H(2)O(2)) -dependent dilations to acetylcholine in isolated mouse cerebral arteries. The purpose of this study was to investigate whether H(2)O(2) was involved in flow-mediated dilation (FMD).
Cerebral arteries were isolated from 12+/-2-week-old C57Bl/6 male mice. FMD (0 to 10 microL/min, 2-microL step increase at constant internal pressure) was induced in vessels preconstricted with phenylephrine (30 micromol/L). Simultaneously to diameter acquisition, H(2)O(2) or nitric oxide production was detected by the fluorescent dyes CMH(2)CFDA or 4,5-diaminofluorescein diacetate, respectively. Results are expressed as mean+/-SEM of 6 to 8 mice.
FMD (at 10 microL/min, 25+/-3% of maximal diameter) was prevented (P<0.05) by endothelium removal (6+/-1%) or endothelial nitric oxide synthase inhibition with N-nitro-L-arginine (11+/-1%) but not by the specific nitric oxide scavenger 2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl3-oxide (24+/-3%). Addition of PEG-catalase and silver diethyl dithio-carbamate (superoxide dismutase inhibitor) reduced (P<0.05) FMD to 10+/-2% and 15+/-1%, respectively. Simultaneously to FMD, H(2)O(2)-associated rise in fluorescence (+133+/-19 a.u.) was prevented by N-nitro-L-arginine, PEG-catalase, and silver diethyl dithio-carbamate (+55+/-10, +64+/-4, and +50+/-10 a.u., respectively; P<0.05). Inhibition of FMD by PEG-catalase was fully restored by the addition of tetrahydrobiopterin, a cofactor of endothelial nitric oxide synthase (23+/-3%); this functional reversal in dilation was associated with the simultaneous increase in nitric oxide-associated fluorescence (+418+/-58 a.u., P<0.05), which was prevented by 2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl3-oxide (+93+/-26 a.u.). Akt inhibition with triciribine prevented FMD and H(2)O(2)-associated rise in fluorescence (3+/-1% and +23+/-4% a.u., respectively; P<0.05), but not acetylcholine-induced dilation.
In healthy C57Bl/6 mouse cerebral arteries, Akt-dependent activation of endothelial nitric oxide synthase-derived H(2)O(2) mediates flow-dependent dilation.
内皮型一氧化氮合酶在生理条件下产生超氧化物,导致离体小鼠脑动脉中出现依赖过氧化氢(H₂O₂)的乙酰胆碱介导的血管舒张。本研究旨在探讨H₂O₂是否参与血流介导的血管舒张(FMD)。
从12±2周龄的C57Bl/6雄性小鼠分离脑动脉。在用去氧肾上腺素(30 μmol/L)预收缩的血管中诱导FMD(0至10 μL/min,在恒定内压下以2 μL步长增加)。在获取血管直径的同时,分别通过荧光染料CMH₂CFDA或4,5-二氨基荧光素二乙酸检测H₂O₂或一氧化氮的产生。结果以6至8只小鼠的平均值±标准误表示。
去除内皮(6±1%)或用N-硝基-L-精氨酸抑制内皮型一氧化氮合酶(11±1%)可阻止FMD(在10 μL/min时,为最大直径的25±3%)(P<0.05),但特异性一氧化氮清除剂2-苯基-4,4,5,5-四甲基-咪唑啉-1-氧基3-氧化物不能阻止(24±3%)。添加聚乙二醇过氧化氢酶和二乙氨基二硫代甲酸银(超氧化物歧化酶抑制剂)分别将FMD降低(P<0.05)至10±2%和15±1%。与FMD同时,N-硝基-L-精氨酸、聚乙二醇过氧化氢酶和二乙氨基二硫代甲酸银分别使与H₂O₂相关的荧光增加(+133±19任意单位)受到抑制(分别为+55±10、+64±4和+50±10任意单位;P<0.05)。聚乙二醇过氧化氢酶对FMD的抑制作用通过添加内皮型一氧化氮合酶的辅因子四氢生物蝶呤完全恢复(23±3%);这种血管舒张功能的逆转与一氧化氮相关荧光同时增加(+418±58任意单位,P<0.05)相关,而2-苯基-4,4,5,5-四甲基-咪唑啉-1-氧基3-氧化物可阻止这种增加(+93±26任意单位)。用三环己基锡抑制Akt可阻止FMD和与H₂O₂相关的荧光增加(分别为3±1%和+23±4%任意单位;P<0.05),但不能阻止乙酰胆碱诱导的血管舒张。
在健康的C57Bl/6小鼠脑动脉中,Akt依赖的内皮型一氧化氮合酶衍生的H₂O₂激活介导血流依赖性血管舒张。